A recent study suggests that people who come off popular weight-loss injections like semaglutide or tirzepatide tend to recover lost weight far faster than those who end conventional diet and exercise plans.
Published data in a leading health publication demonstrates that while obese people can lose a large proportion of their total mass while undergoing treatment, the weight returns at an average rate of 0.8 kg per month after stopping.
"Individuals purchasing these treatments should be aware of the danger of quick rebound weight gain when the therapy is stopped," stated lead investigator Dr. Susan Jebb.
That rate of regain suggests a return to original weight in about 18 months.
Analyzing Treatments
The analysis, which examined dozens of studies involving thousands of patients, compared the effects of the injectable medications with older methods.
Scientists emphasize that people who lose weight through diet and exercise usually see a slower creep back—around 100 grams monthly—post-intervention.
Understanding the Rapid Rebound
Nutrition scientists propose the mode of action of the injections accounts for the heightened rebound.
The injections mimic a body's own chemical called glucagon-like peptide-1, which helps regulate hunger.
"Long-term administration of the hormone levels several times higher than normal may cause the system to generate a reduced amount of its own natural GLP-1, and could lessen sensitivity to its actions," explained Dr. Adam Collins, a dietetics researcher.
"Discontinuation of this hormone supplement means appetite is no longer kept in check, making overeating a significant risk."
An Ongoing Condition?
Health authorities suggest the injections for individuals with weight-linked medical conditions, alongside prescribed lifestyle changes.
Professionals contend that, given the high risk of weight regain, the therapy should be considered long-term.
This view is echoed by drug manufacturers, who say that the results "emphasize the persistent character of excess weight," akin to managing diseases like hypertension.
User Accounts
Individuals who have discontinued the jabs explain a intense resurgence of cravings.
"It felt as if a trigger flipping and you become extremely hungry," described a patient.
The struggle is exacerbated if patients have not established sustainable dietary or behavioural modifications during therapy.
Growing Adoption
Survey data show that millions of adults in the UK have used these injections in the last 12 months, with demand remaining high.
- Use is greater among females than males.
- The 40s and 50s age group shows the greatest level of interest.
- Many access the drugs through private prescriptions rather than public health services.
Ultimately, experts emphasize that while GLP-1 drugs are potent agents for weight loss, they are not a magic cure and lasting health benefits hinges on combined lifestyle support.
